Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IMATINIB MESYLATE, with a corresponding US DMF Number 27089.
Remarkably, this DMF maintains an Active status since its submission on May 09, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 20, 2013, and payment made on May 13, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II